Literature DB >> 24127502

The aetiology of community-acquired pneumonia and implications for patient management.

A B van Gageldonk-Lafeber1, P C Wever, I M van der Lubben, C P C de Jager, A Meijer, M C de Vries, K Elberse, M A B van der Sande, W van der Hoek.   

Abstract

PURPOSE: Understanding which pathogens are associated with clinical manifestation of community-acquired pneumonia (CAP) is important to optimise treatment. We performed a study on the aetiology of CAP and assessed possible implications for patient management in the Netherlands.
METHODS: Patients with CAP attending the emergency department of a general hospital were invited to participate in the study. We used an extensive combination of microbiological techniques to determine recent infection with respiratory pathogens. Furthermore, we collected data on clinical parameters and potential risk factors.
RESULTS: From November 2007 through January 2010, 339 patients were included. Single bacterial infection was found in 39% of these patients, single viral infection in 12%, and mixed bacterial-viral infection in 11%. Streptococcus pneumoniae was the most frequently identified pathogen (22%; n=74). Infection with atypical bacteria was detected in 69 (20%) of the patients.
CONCLUSION: Initial empirical antibiotics should be effective against S. pneumoniae, the most common pathogen identified in CAP patients. The large proportion of patients with infection with atypical bacteria points to the need for improved diagnostic algorithms including atypical bacteria, especially since these atypical bacteria are not covered by the first-choice antibiotic treatment according to the recently revised Dutch guidelines on the management of CAP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24127502

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  16 in total

1.  High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia.

Authors:  A J M Loonen; C Kesarsing; R Kusters; M Hilbink; P C Wever; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-29       Impact factor: 3.267

2.  Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines.

Authors:  H J Zar; D P Moore; S Andronikou; A C Argent; T Avenant; C Cohen; R J Green; G Itzikowitz; P Jeena; R Masekela; M P Nicol; A Pillay; G Reubenson; S A Madhi
Journal:  Afr J Thorac Crit Care Med       Date:  2020-10-13

3.  Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies.

Authors:  Seyi D Eletu; Carmen L Sheppard; Elizabeth Thomas; Kenneth Smith; Priya Daniel; David J Litt; Wei Shen Lim; Norman K Fry
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

Review 4.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  L Hogerwerf; B DE Gier; B Baan; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2017-09-26       Impact factor: 4.434

5.  Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands.

Authors:  Cornelia C H Wielders; Annemarie M H Wuister; Veerle L de Visser; Monique G de Jager-Leclercq; Cornelis A R Groot; Frederika Dijkstra; Arianne B van Gageldonk-Lafeber; Jeroen P G van Leuken; Peter C Wever; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.

Authors:  Jan C Holter; Fredrik Müller; Ola Bjørang; Helvi H Samdal; Jon B Marthinsen; Pål A Jenum; Thor Ueland; Stig S Frøland; Pål Aukrust; Einar Husebye; Lars Heggelund
Journal:  BMC Infect Dis       Date:  2015-02-15       Impact factor: 3.090

Review 7.  The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.

Authors:  Eili Y Klein; Bradley Monteforte; Alisha Gupta; Wendi Jiang; Larissa May; Yu-Hsiang Hsieh; Andrea Dugas
Journal:  Influenza Other Respir Viruses       Date:  2016-06-24       Impact factor: 4.380

8.  Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study.

Authors:  Lena M Mayer; Christian Kahlert; Frank Rassouli; Pietro Vernazza; Werner C Albrich
Journal:  Pneumonia (Nathan)       Date:  2017-02-25

9.  Livestock-associated risk factors for pneumonia in an area of intensive animal farming in the Netherlands.

Authors:  Gudrun S Freidl; Ineke T Spruijt; Floor Borlée; Lidwien A M Smit; Arianne B van Gageldonk-Lafeber; Dick J J Heederik; Joris Yzermans; Christel E van Dijk; Catharina B M Maassen; Wim van der Hoek
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

10.  Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP).

Authors:  Eun Sun Kim; Kyoung Un Park; Sang Hoon Lee; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Choon-Taek Lee; Jae Ho Lee
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.